SCHEMBL13475765

SCHEMBL13475765

C=C1N(CCCNC(=O)C2COc3ccccc3O2)C(=N)NC1(CCCC)CCCC

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HPGD P15428 5/20 0.60
GAA P10253 2/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2D6 P10635 1/20 0.52
CYP2C19 P33261 1/20 0.52
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
POLB P06746 1/20 0.48
TSHR P16473 1/20 0.45
KDM4E B2RXH2 2/20 0.44
HTT P42858 1/20 0.42
ALDH1A1 P00352 4/20 0.42
RAB9A P51151 1/20 0.42
MAPT P10636 2/20 0.42
ALOX5 P09917 1/20 0.42
NPC1 O15118 1/20 0.41
LMNA P02545 1/20 0.41
MAPK1 P28482 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7521313 0.92 HPGD (0.61) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL8178243 0.90 HPGD (0.60) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL13557901 0.88 HPGD (0.59) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL7523294 0.82 HPGD (0.63) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL8412208 0.77 HPGD (0.59) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL13723048 0.76 HPGD (0.42) HPGDMEN1KMT2ATSHRKDM4E
SCHEMBL14923269 0.74 HPGD (0.68) HPGDGAACYP3A4CYP2D6CYP2C19
SCHEMBL7520450 0.72 KMT2A (0.44) HPGDGAACYP3A4CYP2C19MEN1
SCHEMBL7519256 0.70 SMN1; SMN2 (0.54) HPGDKMT2ATSHRKDM4EHTT
SCHEMBL7522362 0.69 GBA1 (0.44) CYP3A4CYP2D6CYP2C19POLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2153832-B1 HETEROCYCLIC ASPARTYL PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2016-03-09 EP disclosed
EP-2153832-A2 Heterocyclic aspartyl protease inhibitors SCHERING CORPORATION (US) 2010-02-17 EP disclosed